Social interactions play an increasingly recognized key role in bacterial physiology 1 . One of the best studied is quorum sensing (QS), a mechanism by which bacteria sense and respond to the status of cell density 2 . While QS is generally deemed crucial for bacterial survival, QS-dysfunctional mutants frequently arise in in vitro culture. This has been explained by the fitness cost an individual mutant, a 'quorum cheater', saves at the expense of the community 3 . QS mutants are also often isolated from biofilm-associated infections, including cystic fibrosis lung infection 4 , as well as medical device infection and associated bacteraemia [5] [6] [7] . However, despite the frequently proposed use of QS blockers to control virulence 8 , the mechanisms underlying QS dysfunctionality during infection have remained poorly understood. Here, we show that in the major human pathogen Staphylococcus aureus, quorum cheaters arise exclusively in biofilm infection, while in non-biofilm-associated infection there is a high selective pressure to maintain QS control. We demonstrate that this infection-type dependence is due to QS-dysfunctional bacteria having a significant survival advantage in biofilm infection because they form dense and enlarged biofilms that provide resistance to phagocyte attacks. Our results link the benefit of QS-dysfunctional mutants in vivo to biofilm-mediated immune evasion, thus to mechanisms that are specific to the in vivo setting. Our findings explain why QS mutants are frequently isolated from biofilm-associated infections and provide guidance for the therapeutic application of QS blockers.
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The benefits of QS dysfunctionality (quorum cheating) have mostly been investigated in vitro. To our knowledge, only two studies addressed the fate of QS-dysfunctional isolates (quorum cheaters) in vivo, by using mixtures of wild-type and isogenic QS-deficient strains for infection; one study used a Pseudomonas aeruginosa wound infection model 9 , and the other assessed Staphylococcus aureus virulence in a wax moth (Galleria melonella) larva infection model 10 . Both studies concluded that the dynamics of in vivo QS functionality follow the in vitro social cheating model, since results were explained by exploitation of cooperative signalling and production of common-good secreted factors by QS cheaters, rather than by host interaction 9, 10 . Despite this previous use of in vivo infection models, in vivo QS dysfunctionality has not been investigated mechanistically in light of the host environment and the presence of host defences. Furthermore, the rise of spontaneous QS mutants has not been directly assessed in an animal infection model. Finally, it is not known why QS mutants preferentially arise in biofilm-associated types of infection.
To analyse the role and development of QS dysfunctionality during infection, considering both biofilm-associated and nonbiofilm-associated infection, we chose the major human pathogen S. aureus because it is a leading cause of both infection types 11 . S. aureus has one well-described QS system called accessory gene regulator (Agr), which controls the production of virtually all secreted degradative enzymes and immune evasion factors such as toxins 12 . In addition, Agr promotes biofilm maturation 13 . Combining cytolytic and surfactant activities, the amphiphilic phenol-soluble modulin (PSM) peptides are key effectors of staphylococcal QS, facilitating both biofilm maturation and toxin-mediated pathogenesis [14] [15] [16] . Previous in vitro observations indicated potential mechanisms to explain occurrence and in vivo benefits of Agr-dysfunctional mutants in a clinical setting 17 . These included findings of an inverse correlation of Agr expression and antibiotic resistance 18 , increased fitness cost of Agr over-expression triggered by selected antibiotics 19 , in addition to our previous observations of extended biofilm formation by agr mutants 5, 14, 20 . However, Agr dysfunctionality has not been directly investigated in vivo. According to previous research by Shopsin et al., agr mutants do not transfer between patients 21 , implying that the rise of S. aureus QS dysfunctionality is not a population-wide process but occurs anew in every individual infection. Consequently, its investigation in an animal infection model should reflect real life.
We measured the development of QS dysfunction in S. aureus in vitro for comparison with our in vivo study. To that end, we monitored the rise of Agr-dysfunctional bacteria in nine methicillin-resistant S. aureus (MRSA) strains and one laboratory strain by serial passage of bacterial cultures. QS-dysfunctional isolates developed at considerable rates in most strains ( Supplementary Fig. 1 ). In some strains, QS dysfunctionality was found to temporarily reach almost 100% of the bacterial population. We frequently detected the 'rebound effect' predicted from the selective pressure that arises because in a population completely devoid of QS-controlled secreted degradative enzymes, bacteria cannot acquire essential nutrients 3 .
In accordance with the notion that QS-controlled enzymes are needed to degrade essential food sources, growth of a culture of exclusively QS-deficient (Δagr) bacteria was significantly impaired in comparison to isogenic wild-type bacteria ( Supplementary Fig. 1 ). Thus, in agreement with established models, in vitro QS dysfunctionality is widespread and considerable in extent in S. aureus but Letters NaTure MicrObiOlOgy a complete 'take over' by quorum cheaters is prevented due to the growth defects of entirely QS-deficient communities. We then investigated QS functionality in vivo. We used two mouse infection models, a device-related, biofilm-associated infection model and a non-biofilm-associated abscess model. We chose the abscess model as example of a non-biofilm-related model due to its otherwise high similarity to the device-related model in terms of infection site and kinetics 16, 22 . We used the MRSA strain LAC (pulsed-field type USA300) because USA300 isolates (1) highly express Agr (ref. 23 ), thus representing an optimal choice to investigate Agr-dependent differences, and (2) were the most frequent causes of S. aureus infections, including device-associated infections, in the United States, in the last decade 24, 25 In the non-biofilm model, Agr-functional (wild-type) bacteria demonstrated significant survival advantages over isogenic agr-negative bacteria (Fig. 1a) . Furthermore, pathogenesis in terms of abscess size was clearly enhanced in the presence of Agr ( Supplementary Fig. 2 ). These findings agree with the fact that Agr regulates a plethora of factors specifically needed for in vivo pathogenesis 26, 27 , including the PSMs, which showed a significant effect on abscess size and bacterial survival (Fig. 1a , Supplementary Fig. 2 ). We did not find any QS-dysfunctional mutants in >1,000 tested bacteria isolated from 7-day-old abscesses caused by the wild-type strain (Table 1 ). These findings indicate that rise of Agr dysfunctionality is strongly suppressed during S. aureus non-biofilm infection. This contrasts with the in vitro data we obtained, indicating that the importance of QS-controlled factors that are specific to survival during infection in vivo supersedes the effects that allow the rise of quorum cheaters in vitro.
Prompted by the studies that have reported the isolation of QS-dysfunctional mutants from chronic and biofilm-associated staphylococcal infections on indwelling medical devices 5, 6 and associated bloodstream infections 7, 28 , we then analysed the development and consequences of Agr dysfunctionality in a mouse model of biofilm-associated infection. We chose a model of subcutaneous device-associated infection, as this model is well-established and pathogenesis is known to depend on biofilm formation on the subcutaneously placed catheter 29 . In contrast to the non-biofilmassociated abscess model, the isogenic agr and psm mutants had significant survival advantages over the wild-type strain on the implanted device (Fig. 1b) . These results agree with our previous findings demonstrating Agr-and PSM-mediated effect on biofilm expansion in vitro 14 but which so far had not been verified for in vivo relevance. We detected the development of QS mutants at a frequency of ~5 × 10 −3 over the one-week duration of the infection, which represents a significant difference to the absence of QS mutants in the abscess model (P = 0.0196, Fisher's exact test; Table 1 ). All mutations were nonsense or missense point mutations that occurred in the agrA or agrC genes (Supplementary Table 1 ), which represent the previously identified main sites of agr mutations in clinical strains 6 . As in this commonly used biofilm infection model, the infection heals in about one week, the expected further expansion of the initial rise of QS mutants cannot be directly measured. Therefore, we used mixed wild-type/agr mutant (1:1) inocula and measured the fate of QS mutants by determining the wild-type/mutant percentage in the biofilm and non-biofilm infection models after one week (Fig. 1c,d) . Strikingly, the percentage of agr mutants in the non-biofilm skin infection model dropped from 50% to 0.3 ± 0.2%, providing further evidence that during non-biofilm infection, functionality of Agr is imperative and quorum cheaters are strongly selected against (Fig. 1e) . In contrast, in the device-associated biofilm infection model, the 
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NaTure MicrObiOlOgy observed percentage of agr mutants after one week of infection was 72.2 ± 25.4%, a significant increase over the inoculum. These data show that the development of QS mutants can be directly demonstrated in a biofilm infection model and that Agr-dysfunctional mutants have a significant advantage in biofilm compared to nonbiofilm infection. The data also indicate that the clinical observation of QS dysfunctionality in chronic biofilm infection can be explained by a survival advantage exhibited by QS-dysfunctional isolates under such conditions. Importantly, our results show that the development of QS dysfunctionality is specific for biofilm infection while strongly suppressed in non-biofilm infection. We then set out to provide a mechanistic explanation for the observed survival advantage of QS-dysfunctional strains in biofilmassociated infection. The major mechanisms of innate host defence controlling the development of S. aureus infection are phagocytosis and killing of bacteria by leukocytes, among which neutrophils and macrophages are the most abundant. We determined whether structural differences between QS-positive and QS-negative biofilms affect resistance to killing by neutrophils and macrophages. Use of a live cell-specific stain showed that QS-dependent differences of biofilm structures were even more pronounced than our previous results using propidium iodide (PI), which stains the overall biofilm due to its interaction with extracellular DNA, had indicated 14 . QS-functional biofilms only consisted of sporadic microcolonies embedded in eDNA, while QS-dysfunctional or PSM-deficient biofilms formed compact layers composed mainly of living cells (Fig. 2a) .
We found that the extended and compact biofilms formed by Agrand PSM-deficient S. aureus 14 showed strongly decreased chances for neutrophil penetration (Fig. 2a,b) . In contrast to the dense biofilms formed by the agr mutant, wild-type biofilms did not prevent phagocytosis (Supplementary Fig. 3 ). Furthermore, in higher Biofilms were grown for 48 h and neutrophils were added at equal numbers. The top rows show biofilm structures without neutrophils, and the other three rows with neutrophils from two different angles ('diamond' view from above and side view), as well as with only SYTO 9 staining in side view. CLSM experiments were repeated at least once giving similar results. b, Neutrophil penetration into the biofilm, on the basis of SYTO 9-only stain. The total number of neutrophils for every strain in the shown field of view was analysed: n = 24 (LAC), n = 13 (LACΔagr), n = 8 (LACΔpsm), n = 12 (252), n = 8 (252Δagr), n = 16 (N315). Statistical analysis is by one-way ANOVA with Dunnett's post-test versus WT (wild-type, for LAC series), and by unpaired two-tailed t-tests for 252 versus 252Δagr. *P <0.0001. Error bars show the mean ± s.d. c, Example CLSM side-view images in higher magnification. Note structures that can be interpreted as pseudopodia attempting to (unsuccessfully) engulf bacteria in the QS-deficient mutant biofilm. See Supplementary Fig. 4 for pictures of the corresponding experiments performed with human macrophages.
NaTure MicrObiOlOgy magnification of neutrophil interaction with Agr-dysfunctional biofilms, we observed morphologies that could be interpreted as 'pseudopodia' attempting to engulf bacteria but which seemed to fail due to biofilm density (Fig. 2c) . Confirming the importance of these observations using a quantifiable assay, we detected significantly increased resistance to neutrophil-mediated killing by Agr-and PSM-deficient as compared to wild-type biofilms (Fig. 3) . Similar observations were made for M1 and M2 macrophages but M2 macrophages generally had much lower capacity to eliminate bacteria than M1 macrophages, which are known to have more pronounced bactericidal activity 30 ( Fig. 3, Supplementary Fig. 4 ). We also investigated biofilm-mediated resistance to neutrophil killing of two standard isolates belonging to pulsed-field type USA100, a major MRSA lineage linked with hospital-associated infections 24 : N315, which is known to be Agr-dysfunctional and 252, which was compared to an isogenic agr mutant. Results with the agr-deficient N315 and 252 Δagr were very similar to those obtained with the LAC (USA300) agr mutant (Figs. 2 and 3) . Altogether, these findings serve as a mechanistic explanation of our in vivo observations, indicating that QS dysfunctionality is subject to positive selection under conditions that are specific to the in vivo biofilm setting.
To directly link our in vivo findings to the observed biofilm-mediated immune evasion mechanism, we performed the biofilm-associated infection model under treatment with cyclophosphamide, which destroys all leukocytes. As expected from this elimination of a major arm of innate host defence, c.f.u. recovered 
NaTure MicrObiOlOgy from mice infected with wild-type bacteria were much higher in cyclophosphamide-treated as compared with non-treated mice (Fig. 4a) . The significant survival advantage that biofilms of Agror PSM-dysfunctional bacteria had in wild-type mice disappeared in cyclophosphamide-treated mice, indicating that this advantage is due to protection from leukocyte attacks. Furthermore, we observed no development of QS-dysfunctional mutants in the biofilm infection model with cyclophosphamide treatment, in significant contrast to the data obtained without cyclophosphamide treatment (P = 0.0188, Fisher's exact test; Table 1 ). Finally, in the biofilm infection model with 1:1 wild-type/agr mutant inoculation, the percentage of agr mutants dropped from ~50% to 16.5 ± 10.0% when cyclophosphamide was applied, a significant difference to the rise observed without cyclophosphamide (Fig. 4b,c) . Together, these findings support the notion that the survival advantage of quorum cheaters and the development of QS dysfunctionality during biofilm infection are due to the specific structure of QS-dysfunctional biofilms that provide increased resistance to phagocyte attacks.
In conclusion, we found that the in vivo advantage of QS dysfunctionality and the rise of QS-dysfunctional mutants (quorum cheaters) is linked specifically to biofilm-associated infection. Our data mechanistically explain this infection-type dependence by the increased resistance biofilms composed of QS-dysfunctional bacteria provide to killing by phagocytes. Thus, our results indicate that QS functionality during infection is predominantly governed by the interaction of QS-controlled factors with host defences. They explain the clinical observation of frequent QS mutant isolation from biofilm and device-associated blood infections 4, 5, 7 . Moreover, they might explain in part why epidemiologically successful isolates of predominantly hospital-associated MRSA lineages (such as USA100) have low Agr expression or are even Agr-dysfunctional (such as N315; ref. 23 ). Our results also support the idea that the PSMs are key contributors to the virulence and biofilm phenotypes mediated by Agr QS in S. aureus. Of particular interest, previous studies have indicated that quorum cheating generally occurs in bacterial infection to a considerable extent, implying severe and universal limitations to the applicability of QS blockers as therapeutics 9, 10 . In contrast, our data indicate, and mechanistically underscore, that QS blockers are inadvisable for biofilm infection, but support the proposed therapeutic use of QS blockers in non-biofilm infection types.
Methods
Bacterial strains and culture conditions. The construction of the psm and agr isogenic mutants in the S. aureus USA300 LAC and 252 background strains have been described previously 16, 27, 31 . For in vitro experiments, bacteria were grown in tryptic soy broth (TSB) or TSBg (TSB with 0.5% glucose, for biofilm experiments). S. aureus strains were obtained from NARSA (Network on Antimicrobial Resistance in S. aureus: LAC, MW2, 8325-4, N315, 252) or are from a University of California San Francisco collection 32 and kindly provided by Dr B. Diep.
Analysis of QS dysfunctionality and serial passage experiments.
Similar to several previous studies 6, 33 , we used haemolytic activity as a readout for Agr functionality in isolates obtained from in vitro or in vivo experiments. Most mutants that lose haemolytic capacity reportedly show spontaneous mutations in the Agr system 6, 33 . We verified the mutation site by sequencing in the infection isolates (Supplementary Table 1) .
For the serial passage experiments, cultures were grown in TSB for 24 h in 15 ml round-bottom tubes and fresh cultures were inoculated every day using 1/200 volume of the previous culture. On days 7, 14, 21, 35 and 42, dilutions were plated on sheep blood agar and haemolysis was evaluated after overnight incubation at 37 °C. The experiment was performed in duplicate.
Neutrophil and macrophage experiments. Human neutrophils and elutriated monocytes were obtained from healthy donors from the NIH blood bank in accordance with protocols approved by the Institutional Review Board for Human Subjects, National Institute of Allergy and Infectious Diseases (NIAID). Informed written consent was obtained from all volunteers. Human neutrophils were isolated as previously described 34 . Elutriated blood monocytes were cultured in RPMI-1640 medium (Life Technologies) supplemented with 10% heat-inactivated Human AB Serum (Gemini Bioproducts), 2 mm ʟ-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 1× MEM nonessential amino acids, 100 U ml −1 penicillin, 100 μg ml −1 streptomycin, and 50 μM 2-ME (all from Life Technologies) at a concentration of 1 × 10 6 cells ml −1 . To induce macrophage differentiation, macrophage colonystimulating factor or granulocyte-macrophage colony-stimulating factor (Pepro-Tech) were added to the cell cultures at a final concentration of 50 ng ml −1 . Medium was supplemented every 2 to 3 days. After 7 days, adhered macrophages were collected by incubating the cells in cold PBS for 15 min on ice and gentle pipetting.
For analysis of biofilm resistance to neutrophil or macrophage killing, biofilms were grown in TSBg for 48 h in 96-well microtiter plates after inoculation using the same amount of bacteria for all strains. Biofilms were then exposed to equal numbers of neutrophils or macrophages (MOI ~10:1 for wild-type S. aureus versus leukocytes, a factor that is somewhat higher for the Δpsm and Δagr mutants due to stronger biofilm formation), and bacterial survival was measured every 30 min up to 90 min for neutrophils and 180 min for macrophages. Investigators were blinded as for group allocation in the respective experiment.
Confocal laser scanning microscopy. Biofilms of the wild-type and isogenic S. aureus strains were inoculated from a pre-culture grown for 3 h in TSBg to an optical density OD 600 of 0.1 in a Nunc Lab-Tek II Chamber Slide System, and grown at 37 °C for 48 h in the same media. They were then stained first with PI (15 min) and then with SYTO 9 (50 nM, 30 min). Human neutrophils or macrophages were isolated as above and stained with 20 μM CellTrace Violet Cell Proliferation Dye (C34557, Life Technology). Stained neutrophils or macrophages were added to grown biofilms and imaged after 30 min (neutrophils) or 2 h (macrophages) of incubation at 37 °C with a Zeiss LSM 700 Laser Scanning Microscope using three confocal channels (405 nm laser for the neutrophils or macrophages stained in violet, 555 nm laser for the PI-stained staphylococcal biofilm, and 488 nm for SYTO 9) .
Confocal images were analysed using the Zen 2010B SP1 software version 6.00.485 and saved as .lsm files. These .lsm files were converted into .ims (IMARIS) files for biofilm statistical analyses and image production in IMARIS. Total and average biovolumes were calculated in IMARIS version 9.0.0. Mean thickness was calculated using the Biofilm Analysis XTension (Bitplane) in IMARIS version 9.0.0. XTension was written for Imaris 8.2.0 using Matlab 2015a. Penetration of neutrophils into the biofilm layer was quantified manually by subtracting the bottom Z layer value of the green (SYTO 9) channel from the bottom Z layer values for each of the cells in the yellow (neutrophil) channel. These values show how far the bottom of each cell has penetrated into the biofilm.
Agr sequencing. The agr system was sequenced in its entirety using the oligonucleotides listed in Supplementary Animal experiments. All mouse experiments were performed at the animal care facilities of NIAID in accordance with ethical guidelines approved by the Animal Care and Use Committee of NIAID. All animals were euthanized by CO 2 at the end of the studies. C57BL/6 J mice were purchased from Jackson. All experiments were performed using age-matched females, 6-10 weeks old. No specific statistical consideration was taken in determining the sample size for the animal experiments.
The mouse skin infection model was performed essentially as previously described 16 . Briefly, ~1 × 10 7 c.f.u. of bacteria in 50 μl of PBS were injected subcutaneously into the left and/or right flank of shaved mice. For the 1:1 (wild-type/Δagr) mixed infection model, ~5 × 10 6 c.f.u. of each strain were injected together in 100 μl of PBS. Total abscess sizes were measured at 24-h intervals for a total of 6 days after infection using an electronic caliper, as described 27 . Open lesion sizes were determined at 24-h intervals using an IVIS Lumina XR imager (Perkin Elkins) with the following settings: field of view 12. . To determine the bacterial load, abscesses on day 6 were surgically removed, cut into small pieces and split into four separate tubes containing 500 μg of borosilicate glass beads and 500 μl of sterile PBS. The skin pieces were homogenized in a FastPrep 96 (MP Bio) homogenizer, 5 × 1 min at 1800 r.p.m. The homogenates were then plated, incubated at 37 °C for 24 h and enumerated. Proportions of wild-type versus Δagr bacteria were determined by plating on tryptic soy agar (TSA), where both grow, and TSA with 3 μg ml −1 tetracycline, where only Δagr bacteria grow due to the tetracycline resistance gene introduced to replace the agr locus.
The catheter infection model was performed essentially as described previously 35 . Briefly, 1-cm catheter pieces were coated with equal numbers of bacteria. Adherence was tested in control experiments and was in the same range (~1 × 10 3 -10 4 ), with wild-type generally adhering better than Δagr or Δpsm bacteria. For the 1:1 (wild-type/Δagr) mixed infection model, adherence of wildtype and mutant bacteria was confirmed on five control catheters to be equal (Δagr, 43.4 ± 8.4%). Catheters were then inserted under the dorsal skin of mice. On day 6, catheters were removed and c.f.u. on the catheters and the directly adjacent tissue were determined by plating as above, after performing a validated sonication Letters NaTure MicrObiOlOgy protocol to disrupt bacterial agglomerates on the catheters, and homogenizing the tissue samples using the FastPrep 96 (MP Bio) homogenizer, 1 × 1 min.
For treatment with cyclophosphamide 36 , cyclophosphamide monohydrate (Sigma-Aldrich) was dissolved in water to a concentration of 1.5 mg ml −1 or 1 mg ml −1 and filter-sterilized. Seven days before challenge, mice were given an intraperitoneal injection at a dosage of 150 mg kg −1 of body weight with 2 ml of 1.5 mg ml −1 cyclophosphamide monohydrate. Then mice were treated every 48 h via intraperitoneal injection with cyclophosphamide monohydrate (1 mg ml −1 ) dissolved in 2 ml of sterile water at a dose of 100 mg kg −1 body weight for three times before the infection.
Investigators were blinded as for group allocation when determining c.f.u. in the experiment shown in Fig. 1 and the corresponding Supplementary Fig. 2 .
Statistics. Statistical analysis was performed using Graph Pad Prism version 7.0. All error bars depict the standard deviation (s.d.). Horizontal lines depict the mean. All replicates are biological (from different samples). Tukey or Dunnett post-tests for analysis of variance (ANOVA) correct for multiple comparisons using statistical hypothesis testing.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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